Focal | Crescentic | Mixed | Sclerotic | pvalue | |
---|---|---|---|---|---|
Age (years) | 66.1 ± 11.4 | 66.3 ± 12.5 | 66.7 ± 10.2 | 67.5 ± 8.6 | n.s. |
Male/female, n | 24/22 | 15/17 | 10/8 | 5/1 | n.s. |
MPO-ANCA, n | 40 | 26 | 15 | 5 | n.s. |
PR3-ANCA, n | 3 | 2 | 0 | 0 | |
Both negative, n | 3 | 4 | 3 | 1 | |
eGFR (ml/min/1.73 m2) | 38.1 (22.5–57.4) | 12.0 (7.1–19.7) | 16.5 (8.7–31.6) | 12.4 (9.8–27.4) | <0.0001 |
Serum albumin (g/dl) | 3.4 (2.8–3.7) | 2.7 (2.4–3.3) | 3.1 (2.8–3.7) | 3.8 (3.5–3.9) | <0.01 |
Serum CRP (mg/dl) | 4.13 (1.43–9.62) | 4.98 (1.65–14.0) | 1.21 (0.10–3.93) | 0.16 (0.10–1.10) | <0.001 |
Proteinuria (g/day) | 0.35 (0.21–0.79) | 1.50 (1.04–2.50) | 1.75 (1.07–2.20) | 1.50 (0.25–3.98) | <0.0001 |
Immunosuppressants, yes/no, n | 25/21 | 17/15 | 4/14 | 1/5 | <0.05 |
Histopathological findings | |||||
Normal glomeruli (%) | 73.2 (60.0–81.6) | 17.9 (10.6–28.0) | 35.4 (22.5–43.8) | 11.3 (0–22.0) | <0.0001 |
Crescentic glomeruli (%) | 13.8 (8.9–23.6) | 67.7 (60.0–74.7) | 31.4 (15.6–40.4) | 12.4 (3.3–22.4) | <0.0001 |
Globally sclerotic glomeruli (%) | 6.5 (0–13.4) | 3.2 (0–13.1) | 29.3 (19.0–40.4) | 64.5 (54.9–71.1) | <0.0001 |